Approved

Capromorelin: Uses, Mechanism, and Research Status

Molecular formulaC28H35N5O4
Molecular weight505.6 g/mol
Registered trials0
PubChem CID216208

Anyone researching capromorelin usually wants to know what the compound actually is and how much clinical evidence exists behind it. This overview summarizes what is publicly documented, without going beyond the available data.

What capromorelin is

Capromorelin is a small molecule with the chemical formula C28H35N5O4 and a molecular weight of about 505.6. It is catalogued under PubChem CID 216208. No FDA label details, mechanism description, or pharmacologic class information were available in the data reviewed for this monograph, so no claims about how it acts in the body are made here.

Trial footprint

The clinical trial registry data reviewed for capromorelin shows a count of zero registered trials, and no sample trial records were available to summarize. This means no phase, status, or study detail can be reported at this time based on the data provided.

Reported side effects

No adverse event report data was available for capromorelin in the data reviewed, so no side effect summary can be provided here.

FAQ

What is capromorelin?
Capromorelin is a small-molecule compound identified in chemical databases under PubChem CID 216208, with a molecular formula of C28H35N5O4. Detailed label, mechanism, and indication information were not available in the data reviewed for this monograph.
Is capromorelin FDA approved?
This monograph draws on data marked as approved status, but no specific label indications, brand names, or approved uses were available in the dataset reviewed. Readers should consult official regulatory sources for definitive approval details.
How many clinical trials have studied capromorelin?
The data reviewed lists zero registered clinical trials for capromorelin, and no sample trial records were provided. This limits what can be said about the current clinical evidence base.
What side effects are associated with capromorelin?
No adverse event report data was available in the dataset reviewed for capromorelin, so no side effect pattern can be summarized at this time.
What is the chemical structure of capromorelin?
Capromorelin has the molecular formula C28H35N5O4 and a molecular weight of approximately 505.6. It is catalogued in PubChem under CID 216208.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication. Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.

Sources: PubChem DailyMed ClinicalTrials.gov registry data

Updated 2026-09-26